The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, December 11, 2018
Avanir Pharmaceuticals announced that it will terminate the license agreement with Optinose for intranasal migraine medication ONZETRA Xsail (...
read more
Thursday, December 13, 2018
Adynxx announced receipt of Notice of Award from the NIDA for an award to support the clinical development of brivoligide injection for postoperative ...
read more
Tuesday, December 18, 2018
Croda has signed a definitive agreement with Brenntag Nordic A/S to acquire Brenntag Biosector, for a total consideration of €72 million in cash.
read more
Wednesday, December 19, 2018
Alcon has acquired Tear Film Innovations, a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian ...
read more
Wednesday, December 26, 2018
Braeburn announced the FDA has granted tentative approval of BRIXADI (buprenorphine) extended-release weekly injections.
read more
Friday, December 28, 2018
The FDA has approved VAXELIS for use in children from 6 weeks through 4 years of age. VAXELIS was developed as part of a joint partnership between ...
read more
Friday, December 28, 2018
Kala Pharmaceuticals announced the NDA for KPI-121 0.25% has been accepted for review by the FDA.
read more
Wednesday, January 02, 2019
Heron Therapeutics announced the FDA has accepted the NDA for Heron's investigational agent, HTX-011, and has granted it a Priority Review designation...
read more
Tuesday, January 08, 2019
Sun Pharmaceutical is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg and one lot of Vecuronium Bromide for Injection, 20 ...
read more
Thursday, January 10, 2019
Teva announced the FDA has approved ProAir Digihaler inhalation powder, a digital inhaler with built-in sensors which connects to a mobile app and ...
read more
Q BioMed announced its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
read more
Dr. Reddy’s announced the launch of Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of DIPRIVAN Injectable Emulsion, USP, ...
read more
Wednesday, January 30, 2019
One of our key policy priorities is encouraging the timely development and approval of generics and biosimilars.
read more
Thursday, January 31, 2019
The FDA approved the first generic of Advair Diskus for the twice-daily treatment of asthma and maintenance treatment of COPD.
read more
Monday, February 04, 2019
Biohaven announced that administration of intranasal BHV-3500 in a Phase 1 clinical trial has achieved targeted therapeutic exposures and that the ...
read more